WA House COG - Committee Meeting
(March 25, 2021) - Work Session - WSLCB

Cannabis Regulators Association (CANNRA) - Website - Screenshot

WSLCB Director Rick Garza requested time to update lawmakers ahead of a committee work session on the future of the cannabis industry to share regulator priorities and disclose new agency work groups.

Here are some observations from the Thursday March 25th Washington State House Commerce and Gaming Committee (WA House COG) work session.

My top 3 takeaways:

  • Washington State Liquor and Cannabis Board (WSLCB) Director Rick Garza began by outlining his role on the leadership team of the Cannabis Regulators Association (CANNRA).
    • Garza wanted to address WA House COG members prior to their scheduled work session on March 26th at 10am (“Examining the future of the cannabis industry in Washington state") so that he could “update the committee about the work we are doing with other states” through CANNRA (audio - 1m, video).
    • He discussed the progenitor Regulators Roundtable events which provided representatives from legal cannabis states with a means to connect and share information. He noted the first event in 2017 “was hosted by the LCB here in Olympia” with Washington, Colorado, Alaska, and Oregon represented. Garza said “the roundtable continued to add additional members at subsequent meetings in Portland, Boston, Denver, Juneau, Baltimore, as well as a virtual conference in August 2020. The purpose was to “share best practices and learn from each other as new states came on board,” he explained, noting a supermajority of states had legalized medical or adult use cannabis, or decriminalized some cannabis activities (audio - 1m, video).
      • Garza told colleagues about the last virtual Roundtable in September 2020.
      • Prior to CANNRA’s formation, an internal WSLCB email in February 2020 described suggested discussion topics for the next Roundtable, indicating staff at the time considered the following issues, amongst others, particularly “needed/relevant to our agency.”
        • Tracker update
        • Illicit market tracking
        • High potency products
        • Excipients/flavorings
        • Advertising/Marketing requirements
        • [Cannabidiol] CBD and other cannabinoids
    • In November 2020, CANNRA was announced as comprised of 19 states “to better share institutional knowledge and regulatory best practices.” CANNRA’s membership had since grown to “26 member states plus Washington, D.C.,” he stated, in order to provide “policy makers and regulatory agencies the resources to make informed decisions when considering approaches to cannabis regulation” (audio - 2m, video). 
      • He explained that the group was non-partisan, consisted “solely” of government regulators (“not open to industry”), and would not take a “position for or against legalization” of cannabis. CANNRA strove to provide a “much needed forum for regulators” to “engage with each other to identify and develop best practices, create model policies that safeguard public health and safety, and promote regulatory certainty for those in the industry.”
      • Garza noted that Senator Sam Hunt, the Council of State Governments (CSG) incoming National Chair, had “reached out to us almost, over a year ago” to see whether CANNRA would become “affiliated” with CSG. Hunt relayed that many CSG members “were looking to engage with the cannabis regulators because many other state legislators were looking at legalization for adult use or medical cannabis.” Garza confirmed that CANNRA had affiliated with CSG in the “last month.”
  • Garza said WSLCB staff intended to organize two new external work groups following the legislative session to address delta-8-tetrahydrocannabinol (delta-8-THC) and federal cannabis legalization.
    • Delta-8-THC Work Group (audio - 1m, video)
      • Garza talked about “states working together in the emergence of delta-8” which he said was a “chemically-derived derivative” of cannabidiol (CBD) with psychoactive effects “estimated to be between 50 and 75% potency of today’s THC products.” Since federal hemp legalization in 2018, he claimed “a major market of innovation sprang up in CBD and its derivatives.” He suggested lawmakers "Google it and you will see" numerous “pop up” businesses specializing in a “quasi-legal market" for CBD and delta-8-THC.
      • Garza said unnamed “experts tell us that delta-8 is the first of many that will follow as psychoactive compounds that we’ll see in the future.” He reported that WSLCB planned to establish a work group composed of representatives from the cannabis industry, the Washington State Department of Health (DOH) and the Washington State Department of Agriculture (WSDA). The work group focus would be “to address delta-8 and other psychoactive derivatives leveraged on information from CANNRA discussions.”
        • Learn about the background of WSLCB engagement with delta-8-THC through Garza’s more expansive comments during the March 16th Board Caucus, incidentally David Postman’s first public meeting as Board Chair.
    • Federal Legalization Work Group (audio - 1m, video
      • With an increasing likelihood of national cannabis legalization, Garza said “some of the major cannabis brands in Canada have shared with us that major trade organizations are being formed in anticipation of the lifting of prohibition, such as the U.S. Cannabis Council” (USCC). He had also “been told” that several U.S. Senators “within the next months will issue a draft to possibly deschedule cannabis” from the federal Controlled Substances Act. “While the Biden Administration is perceived as moderate to conservative on cannabis, the industry believes the leadership and work is going to come from Congress,” Garza said.
      • To prepare for this, WSLCB staff would form another work group “to prepare our industry and state for the lifting of federal prohibition of cannabis," which the agency expected would occur “within the next two to four years.” He added that Oregon passed legislation in 2019 in anticipation of legal interstate commerce and assured the committee that “Washington and other states will be looking at similar strategies to ensure that we are ready.”
    • Chair Shelley Kloba offered her gratitude to Garza for taking the initiative to reach out to the committee before the following day’s work session and asked a clarifying question about the agency work groups (audio - <1m, video).
      • Kloba asked Garza to verify that the work groups mentioned would be separate entities. He responded that they were, though the groups “may include many of the same folks. But I see the preparation for legalization federally with the industries and others a little differently than I see tackling the issue of all these new cannabinoids that are being introduced.” Garza also expected that WSLCB would “look to see if we can do some rulemaking around delta-8 if we have the authority to do that." He expected legislation would be prepared for the 2022 legislative session to “to bring all cannabinoids under the regulatory authority” of the agency similar to the Oregon Liquor Control Commission (OLCC) rulemaking Effort to Limit Unchecked Use of Delta-8-THC, Other Artificially-Derived Cannabinoids (audio - 2m, video).
      • Kloba commented that she was “very excited” to see the CANNRA letter included a call for increased cannabis research. She said a “theme” she’d been “hammering on” since joining WA House COG was more research so lawmakers could “make the best possible decisions.” Kloba suggested “joint meetings with CSG and CANNRA” could help inform legislators around the country (audio - 2m, video).
    • Representative Melanie Morgan, a WA SECTF Co-Chair, inquired about how the task force and/or its members could collaborate with the work groups Garza mentioned. He answered that WA SECTF’s work on social equity was already valuable to the agency, adding that "when I say stakeholders I mean everybody" can become part of the work groups if they’re interested. He committed to “make sure that, that everyone’s a part of that discussion” (audio - 1m, video).

Information Set